TB-500 vs Teriparatide
Well Studied vs Extensively Studied
compatible Different mechanisms; no known interactions.
Molecular Data
TB-500 Teriparatide
Weight 4,963.44 Da 4,118 Da
Half-life ~2 hours ~1 hour (subcutaneous); ~5 minutes (intravenous)
Chain 43 amino acids 34 amino acids
Type Thymosin fragment Recombinant PTH fragment
Key Benefits
TB-500
01 Superior systemic tissue repair
02 Accelerated muscle, tendon, and ligament healing
03 Enhanced cell migration and angiogenesis
04 Comprehensive regenerative effects
05 Neuroprotective properties
Teriparatide
01 FDA-approved for osteoporosis treatment
02 Actively builds new bone (anabolic)
03 Increases spine bone density by 5-9%
04 Reduces vertebral fracture risk by 65%
05 Reduces nonvertebral fractures by 35%
06 Works differently than antiresorptive drugs
07 Benefits seen within 3 months
08 Creates 'anabolic window' for bone growth
Dosing Protocols
TB-500
2-5mg per injection (higher doses for serious injuries) / 2-3x weekly (e.g., Monday, Wednesday, Friday)
General tissue repair 2-3mg 2x weekly
Serious injury recovery 4-5mg 3x weekly
Athletic enhancement 2-3mg 2x weekly
Chronic conditions 3-4mg 2-3x weekly
Maintenance 2mg 1-2x weekly
Post-surgical recovery 3-5mg 3x weekly
Teriparatide
20mcg daily (FDA-approved dose) / Once daily at same time each day
Osteoporosis treatment 20 mcg Once daily
Side Effects
TB-500
Generally minimal side effects
Possible mild injection site reactions
Temporary fatigue in some users
Teriparatide
Injection site reactions
Nausea
Headache
Leg cramps
Dizziness
Joint pain
Contraindications
Active cancer treatment (due to angiogenic effects)
Pregnancy or breastfeeding
Immunosuppressive medications (consult provider)
WADA prohibited for competitive athletes
Paget's disease of bone
Prior skeletal radiation therapy
History of skeletal malignancies
Metabolic bone diseases other than osteoporosis
Pre-existing hypercalcemia
Pregnancy
Research Evidence
TB-500 Teriparatide
Status Well Studied Extensively Studied
References 4 studies 4 studies
Latest March 2024 —
FDA Approved No Yes
This comparison is for educational and research purposes only. Consult a healthcare professional before use.